FXYD4
FXYD domain-containing ion transport regulator 4
Also known as: CHIF, FXYD4_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P59646
- Gene
- FXYD4
- Ensembl
- ENSG00000150201
- Chromosome
- 10
- Canonical length
- 89 aa
- Protein class
- Predicted membrane proteins, Transporters
- Subcellular location
- Cytosol
OverviewNCBI Gene
This gene encodes a member of a family of small membrane proteins that share a 35-amino acid signature sequence domain, beginning with the sequence PFXYD and containing 7 invariant and 6 highly conserved amino acids. The approved human gene nomenclature for the family is FXYD-domain containing ion transport regulator. FXYD4, originally named CHIF for channel-inducing factor, has been shown to modulate the properties of the Na,K-ATPase, as has FXYD2, also known as the gamma subunit of the Na,K-ATPase, and FXYD7. Transmembrane topology has been established for FXYD4 and two family members (FXYD1 and FXYD2), with the N-terminus extracellular and the C-terminus on the cytoplasmic side of the membrane. Alternatively spliced transcript variants encoding the same protein have been found.[provided by RefSeq, May 2010]
Canonical amino-acid sequenceUniProt
89 residues, UniProt reviewed canonical sequence.
>P59646|FXYD4
1 MERVTLALLL LAGLTALEAN DPFANKDDPF YYDWKNLQLS GLICGGLLAI AGIAAVLSGK
61 CKCKSSQKQH SPVPEKAIPL ITPGSATTCLocalizationUniProt · AlphaFold · HPA
Whether an antibody against FXYD4 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.58
- Highest tissue expression
- 301 nTPM
Expression across tissuesHPA
Tissue
- kidney: 301 nTPM
- stomach: 6.5 nTPM
- salivary gland: 5.3 nTPM
- seminal vesicle: 2.6 nTPM
- midbrain: 2.3 nTPM
- hippocampal formation: 1.6 nTPM
Single-cell type
- renal collecting duct principal cells: 521 nCPM
- parietal cells: 134 nCPM
- papillary tip epithelial cells: 131 nCPM
- renal connecting tubule cells: 37 nCPM
- loop of henle epithelial cells: 32 nCPM
- renal collecting duct intercalated cells: 24 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- white matter: 3.8 nTPM
- basal ganglia: 3.4 nTPM
- midbrain: 2.5 nTPM
- thalamus: 2.5 nTPM
- hypothalamus: 2.1 nTPM
- cerebral cortex: 1.7 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.49
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.3
- DepMap mean gene effect
- 0.02
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- positive regulation of sodium ion export across plasma membrane
- potassium ion transmembrane transport
- sodium ion transport
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Ion-transport regulator, FXYD family
- Ion-transport regulator, FXYD motif
- ATP1G1/PLM/MAT8 family
- FXYD domain-containing ion transport regulator 4
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads FXYD4 as an antibody target. Whether an autoantibody or antibody against FXYD4 could matter depends on whether native FXYD4 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
FXYD4 is annotated at the cell surface, where native FXYD4 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label FXYD4 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...